Cyclopentenone derivatives for cancer therapy

The invention relates to the use of derivatives of cyclopentenone for the inhibition or prevention of the growth or multiplication of cancer cells, and to therapeutic compositions containing such compounds. The invention relates more specifically to the use of derivatives of cyclopentenone for the i...

Full description

Saved in:
Bibliographic Details
Main Authors NANGIA ASHWINI, SAIRAM KALAPATAPU V.V.M, YADAV J. S, CHANDRASEKHAR SRIVARI, GURJAR MUKUND K, WAKHARKAR RADHIKA D, DESIRAJU GAUTAM R, BURMAN ANAND C, SARKHEL SANJAY, SINGH ANUO T, JAGGI MANU, BORATE HANUMANT BAPURAO, MUKHERJEE RAMA, KAPOOR KAMAL K
Format Patent
LanguageEnglish
Published 11.12.2003
Edition7
Subjects
ACYCLIC OR CARBOCYCLIC COMPOUNDS
ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM
CHEMISTRY
METALLURGY
ORGANIC CHEMISTRY
Online AccessGet full text

Cover

More Information
Summary:The invention relates to the use of derivatives of cyclopentenone for the inhibition or prevention of the growth or multiplication of cancer cells, and to therapeutic compositions containing such compounds. The invention relates more specifically to the use of derivatives of cyclopentenone for the inhibition and/or prevention of cancer of the colon, pancreas, larynx, ovary, duodenum, kidney, oral cavity, prostate, lung, endothelial cells and leukemias
Bibliography:Application Number: US20020309754